FDA grants tentative approval for Dr. Reddy's generic lenacapavir for HIV prevention

The FDA issued a tentative approval for Dr. Reddy's generic version of lenacapavir, Gilead Sciences' twice-a-year injectable HIV prevention drug. The regulatory milestone is a key step in making the drug available in 120 low- and middle-income countries where demand has outstripped supply.

Detected & updated continuously · Source: Nebula